Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BAYLOR COLLEGE OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1900-10-30

Employees: 10K

Market Cap: -

Website: http://www.bcm.edu

Clinical Trials

Bladder Cancer Patient-Reported Outcomes

Completed

Conditions: Bladder Neoplasms

First Posted Date: 2010-03-22

Last Posted Date: 2016-11-09

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 108

Registration Number: NCT01090388

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Rivastigmine as a Treatment for Methamphetamine Dependence

Phase 1

Completed

Conditions: Methamphetamine Dependence
Substance Abuse
Methamphetamine Abuse

Interventions: Other: Placebo
Drug: Rivastigmine

First Posted Date: 2010-02-23

Last Posted Date: 2012-07-27

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 17

Registration Number: NCT01073319

Locations: 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States

Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE)

Phase 1

Completed

Conditions: Adenovirus Infection
Epstein-Barr Virus Infections
Cytomegalovirus Infections
Stem Cell Transplant

First Posted Date: 2010-02-18

Last Posted Date: 2014-09-04

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 10

Registration Number: NCT01070797

Locations: 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸
Texas Children's Hospital, Houston, Texas, United States

NAC as a Potential Treatment for Methamphetamine Dependence

Phase 1

Completed

Conditions: Methamphetamine Abuse
Methamphetamine Dependence
Substance Abuse

Interventions: Drug: Placebo
Drug: N-acetylcysteine

First Posted Date: 2010-02-05

Last Posted Date: 2012-07-27

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 10

Registration Number: NCT01063205

Locations: 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States

An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence

Phase 1

Completed

Conditions: Methamphetamine Abuse
Methamphetamine Dependence
Substance Abuse

Interventions: Drug: Placebo
Drug: Perindopril
Drug: Candesartan

First Posted Date: 2010-02-04

Last Posted Date: 2022-04-26

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 80

Registration Number: NCT01062451

Locations: 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States

The Effects of Doxazosin on the Cardiovascular and Subjective Effects of Cocaine

Phase 1

Completed

Conditions: Cocaine Addiction
Cocaine Abuse
Cocaine Dependence
Substance Abuse

Interventions: Drug: Placebo
Drug: Doxazosin

First Posted Date: 2010-02-04

Last Posted Date: 2012-07-27

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 13

Registration Number: NCT01062945

Locations: 🇺🇸
Michael Debakey VA Medical Center, Houston, Texas, United States

Investigation of Cycloserine as a Smoking Cessation Treatment

Phase 1

Completed

Conditions: Nicotine Addiction

Interventions: Drug: Placebo
Drug: Cycloserine

First Posted Date: 2010-02-04

Last Posted Date: 2012-07-27

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 34

Registration Number: NCT01062932

Locations: 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States

Functional Neuroimaging of Cortical Plasticity in the Human Visual System

Withdrawn

Conditions: Stroke
Vision
Blindness

First Posted Date: 2010-02-04

Last Posted Date: 2022-04-11

Lead Sponsor: Baylor College of Medicine

Registration Number: NCT01062672

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇩🇪
Max Planck Institute for Biological Cybernetics, Tuebingen, Germany

Dexmedetomidine in Pediatric Tonsillectomy

Phase 4

Completed

Conditions: Pediatric Adenotonsillectomy
Post Operative Analgesia

Interventions: Drug: Morphine 50 mcg/kg
Drug: Morphine 100 mcg/kg
Drug: Dexmedetomidine 0.75 mcg/kg
Drug: Dexmedetomidine 1 mcg/kg

First Posted Date: 2010-01-27

Last Posted Date: 2021-07-27

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 109

Registration Number: NCT01057381

Locations: 🇺🇸
Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, United States

Pain and Anxiety Management With Oral Narcotic for Pediatric Suture Repair

Not Applicable

Completed

Conditions: Children
Lacerations
Procedures
Child
Pain

Interventions: Drug: hydrocodone/acetaminophen
Drug: Sugar water

First Posted Date: 2010-01-21

Last Posted Date: 2021-08-25

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 85

Registration Number: NCT01053637

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy